AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 14 filers reported holding AKARI THERAPEUTICS PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,387,000 | -17.3% | 197,072 | 0.0% | 0.60% | -23.1% |
Q3 2016 | $1,677,000 | -36.9% | 197,072 | 0.0% | 0.78% | -57.0% |
Q2 2016 | $2,659,000 | -28.0% | 197,072 | -25.3% | 1.82% | -36.2% |
Q1 2016 | $3,695,000 | -3.4% | 263,921 | 0.0% | 2.86% | -15.8% |
Q4 2015 | $3,827,000 | – | 263,921 | – | 3.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 426,297 | $2,617,000 | 0.72% |
Vivo Capital, LLC | 345,850 | $2,124,000 | 0.43% |
Hikari Power Ltd | 151,334 | $929,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 433,551 | $2,662,000 | 0.12% |
NEA Management Company, LLC | 452,167 | $2,776,000 | 0.10% |
Baker Brothers Advisors | 496,901 | $3,051,000 | 0.02% |
HUNTINGTON NATIONAL BANK | 8,000 | $49,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 115,543 | $709,000 | 0.00% |
DEUTSCHE BANK AG\ | 5,300 | $32,000 | 0.00% |
MORGAN STANLEY | 8,807 | $54,000 | 0.00% |